Management of pancreatic intraductal papillary mucinous neoplasm in an academic hospital (2005-2010): What follow-up for unoperated patients?

Pancreas

Volumn 42, Issue 4, 2013, Pages 696-700

  Baiocchi, Gian Luca ^a   Portolani, Nazario ^a   Grazioli, Luigi ^b   Mazza, Giancarlo ^b   Gheza, Federico ^a   Bartoli, Michele ^a   Vanzetti, Enrico ^b   Giulini, Stefano M ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b BRESCIA CIVIL HOSPITAL   (Italy)

Author keywords

diagnosis; follow up; intraductal papillary mucinous neoplasm (IPMN); pancreas; Sendai criteria

Indexed keywords

CANCER MORPHOLOGY; FOLLOW UP; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PRIORITY JOURNAL; REVIEW;

ACADEMIC MEDICAL CENTERS; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; WATCHFUL WAITING;

EID: 84876878680     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318270b98b     Document Type: Review

References (27)

1. Sarr MG, Murr M, Smyrk TC, et al. Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importanceVcurrent state-of-the-art and unanswered questions. J Gastrointest Surg. 2003; 7: 417-428.
2. Longnecker DS, Hruban RH, Kloppel G. Intraductal-papillary mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. Lyon, France: IARC Press; 2000: 237-240.
3. Obara T, Maguchi H, Saitoh Y, et al. Mucin-producing tumor of the pancreas: Natural history and serial pancreatogram changes. Am J Gastroenterol. 1993; 88: 564-569.
4. Wang SE, Shyr YM, Chen TH, et al. Comparison of resected and non-resected intraductal papillary mucinous neoplasms of the pancreas. World J Surg. 2005; 29: 1650-1657.
5. Hirono S, Tani M, Kawai M, et al. Treatment strategy for intraductal. papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Arch Surg. 2009; 144: 345-349.
6. Maire F, Hammel P, Terris B, et al. Prognosis of malignant intraductal papillary mucinous tumors of the pancreas after surgical resection: Comparison with pancreatic ductal adenocarcinoma. Gut. 2002; 51: 717-722.
7. Wada K, Kozarek RA, Traverso LW. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg. 2005; 189: 632-637.
8. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006; 6: 17-32.
9. Sawhney MS. International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas. Clin Gastroenterol Hepatol. 2009; 7: 1373-1376.
10. Pelaez-Luna M, Chari ST, Smyrk TC, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol. 2007; 102: 1759-1764.
11. Tanno S, Nakano Y, Nishikawa T, et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: Long-term follow-up results. Gut. 2008; 57: 339-343.
12. Waters JA, Schmidt CM, Pinchot JW, et al. CT vs MRCP: Optimal classification of IPMN type and extent. J Gastrointest Surg. 2008; 12: 101-109.
13. Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: Predictors of malignant and invasive pathology. Ann Surg. 2007; 246: 644-651.
14. Sugiyama M, Izumisato Y, Abe N, et al. Predictive factors for malignancy in intraductal papillary-mucinous tumors of the pancreas. Br J Surg. 2003; 90: 1244-1249.
15. Shin SH, Han DJ, Park KT, et al. Validating a simple scoring system to predict malignancy and invasiveness of intraductal papillary mucinous neoplasms of the pancreas. World J Surg. 2010; 34: 776-783.
16. Falconi M, Salvia R, Bassi C, et al. Clinicopathological features and treatment of intraductal-papillary mucinous tumours of the pancreas. Br J Surg. 2001; 88: 376-381.
17. Salvia R, Crippa S, Falconi M, et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: To operate or not to operate? Gut. 2007; 56: 1086-1090.
18. Jang JY, Kim SW, Ahn YJ, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: Is it possible to predict the malignancy before surgery? Ann Surg Oncol. 2005; 12: 124-132.
19. Baiocchi GL, Portolani N, Missale G, et al. Intraductal papillary mucinous neoplasm of the pancreas (IPMN): Clinico-pathological correlations and surgical indications. World J Surg Oncol. 2010; 7: 25-31.
20. Winter JM. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg. 2006; 10: 1199-1211.
21. Baiocchi GL, Portolani N, Bertagna F, et al. Possible additional value of 18FDG-PET in managing pancreas intraductal papillary mucinous neoplasms: Preliminary results. J Exp Clin Cancer Res. 2008; 27: 10-16.
22. Takanami K, Hiraide T, Tsuda M, et al. Additional value of FDG PET/ CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Ann Nucl Med. 2011; 25: 501-510.
23. Maguchi H, Tanno S, Mizuno N, et al. Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: A multicenter study in Japan. Pancreas. 2011; 40: 364-370.
24. Sawai Y, Yamao K, Bhatia V, et al. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy. 2010; 42: 1077-1084.
25. Benarroch-Gampel J, Riall TS. Extrapancreatic malignancies and intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg. 2010; 2: 363-367.
26. Ikeuchi N, Itoi T, Sofuni A, et al. Prognosis of cancer with branch duct type IPMN of the pancreas. World J Gastroenterol. 2010; 16: 1890-1895.
27. Ball CG, Howard TJ. Natural history of intraductal papillary mucinous neoplasia: How much do we really know? World J Gastrointest Surg. 2010; 2: 368-372.